Approval · Notice of Compliance 2782 · 1998
ALPHANINE SD: Notice of Compliance 2782
Issued May 22, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2782
- Date
- May 22, 1998
- Company
- Alpha Therapeutic CorporationLos Angeles, California, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Hemostatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALPHANINE SD | 02210436 | — |
| ALPHANINE SD | 02210444 | — |
| ALPHANINE SD | 02210452 | — |
| ALPHANINE SD | 02210460 | — |
Medicinal ingredients
- COAGULATION FACTOR IX (HUMAN) 300 UNIT per VIAL
- COAGULATION FACTOR IX (HUMAN) 600 UNIT per VIAL
- COAGULATION FACTOR IX (HUMAN) 1,200 UNIT per VIAL
- COAGULATION FACTOR IX (HUMAN) 1,800 UNIT per VIAL